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I '~ '~ Regional Variation In Coronary Revascula~;zation: 
Compar ison of  Bypass Surgery to Angioplssty 
Anthony N. DeMada, W. Randolph Chltwoed, Jr., David O. Williams, 
Douglas L Wood, Jack Davis, Michael J. Wolk, George A. Baiter, Sondra 
S. Bayer. UGSD Medical Center, San Diego, CA 
Although regional variation in *;;~ rate of application has been demonstrated 
for several cardiac proce<f.,:as, the cause of this variation remains uncertain. 
Comnmy bypass SL,~:~y (CABG) and angtoplesty (PTCA) am revascolariza- 
tion procedures w~'..~h differ in several respects, including yearn of existence 
and data avail-~e from randomized rials. Further, CABG usually necessi- 
trees refern~ to another physician, whereas PTCA does sol Therefore, we 
co.m~ ..rod the region~.l variation of CABG and PTCA in the U.S. by analyzing 
the 1992 Part B Medicare claims data for all such procedures performed. 
Data were crwided into the nine standard Medicare geographical regions. 
Slightly more PTCAs were performed than CABG: 410 vs 384 per 100,000 
beneficiaries. Considerable geographic variation was observed for beth pro- 
ceduras, with mean values for low and high performance rotes of 265 to 576 
and 200 to 580 for CABG and PTCA respectively. The New England region 
was unique in having a systematic difference between CABG and PTCA 
(mean 395 vs 288 re3pectively). The range of variation between ragions 
was similar: CABG from 344 (South Atlantic) to 499 (E South Central and 
PTCA from 325 (Mid Atlantic) to 512 ON South Central). Thus, substantial 
geographic variation exists for comnmy revascularization, and is similar for 
CABG and PTCA. Since CABG has a longer existence, more randomized 
trials, and involves patient referral to another physician, other factors likely 
play an important role in regional variatian of these procedures. 
4.'45 
~--~ Wide Variation in Institutional Transesophagssl  
Echo Util ization Affects b Apparent  Value: From 
V.O.T.E. I 
ManjAnn McLaaghlin, Ravin Davidoff, Banico Barzilai, Steve Schwartz, 
Michael Picard, Shunichi Homma, Paul Tunlck, Michael Morro, Zvi Vered, 
Anthony DeMaria, Howard Dittrich, Steven Goldstein. itzhak Kronzon, 
David Vorchheimer, Lamj Baruch, Oma David, MaP;in E. Goldman, for the 
V.O.T.E. I Investigators. Mount Sinai Medical Center, New ~k,  NY 
Tmnsesophageai echocardiography (TEE) is a widely used, costly, physician 
intensive test which may provide unique information ot available from other 
moclaiities. However, there is a wide vad~on in its clinical application. To 
compare utilizat~n pattems of TEE across the country, we compared the 
results obtained from the 11 Sites (A-K) entering the 4600 pte into V.O.T.E. I 
(yalue of Tmnsesophageat _Echo). The study utilized a I page questionnaire 
completed immediately after the TEE by interrogating the referring physicians 
on their perception of the direct impact of the TEE and resultant clinical nvm- 
agement changes (Manage A). The 10 diagnostic (dx) categories included 
stroke or TIA (CVA/TIA) and Valve related diagnoses (native or prosthetic 
valves, endocarditis). 
Site # Pts CVA/TIA % Valve % Manage A % 
A 927 25.0 36.8 38.6 
B 1140 49.3 28.2 24.0 
C 859 12,8 64.1 33,6 
D 432 18.5 56.9 38.9 
E & F 337 17.5 37.1 37.1 
TOTAL 4800 26.8 41.7 ~3,2 
Over 80% of the patients were recmiled fn0m 6 of the 11 institutions. Site 
B had the greatest % of CVA pte (493) but the lowest mpolled intpest of TEE 
on overall Manage L~. The 4 sites with the largest volume of TEE studies 
reported Manage A in 31.0% of thair pts bssed on the TEE, compared to 
46,6% in the remaining aitas which ~ fewer TEE's, Pefcolved Impact 
of TEE n~y vo~ wiih the reforrai pepulaticn and physician expedenca with 
the technique. Since indications for TEE vanj so widely among inotitutions, 
studms to ~ .  the clinical ulitity of TEE am wananted to standardize its 
application. 
